Abstract:Background: High dosage of dexamethasone (Dex) is an effective treatment for multiple diseases; however, it is often associated with severe side effects including muscle atrophy, resulting in higher risk of falls and poorer life quality of patients. Cell therapy with mesenchymal stem cells (MSCs) holds promise for regenerative medicine. In this study, we aimed to investigate the therapeutic efficacy of systemic administration of adipose-derived mesenchymal stem cells (ADSCs) in mitigating the loss of muscle mass and strength in mouse model of DEX-induced muscle atrophy. Methods: 3-month-old female C57BL/6 mice were treated with Dex (20 mg/kg body weight, i.p.) for 10 days to induce muscle atrophy, then subjected to intravenous injection of a single dose of ADSCs ([Formula: see text] cells/kg body weight) or vehicle control. The mice were killed 7 days after ADSCs treatment. Body compositions were measured by animal DXA, gastrocnemius muscle was isolated for ex vivo muscle functional test, histological assessment and Western blot, while tibialis anterior muscles were isolated for RNA-sequencing and qPCR. For in vitro study, C2C12 myoblast cells were cultured under myogenic differentiation medium for 5 days following 100 [Formula: see text]M Dex treatment with or without ADSC-conditioned medium for another 4 days. Samples were collected for qPCR analysis and Western blot analysis. Myotube morphology was measured by myosin heavy chain immunofluorescence staining. Results: ADSC treatment significantly increased body lean mass (10-20%), muscle wet weight (15-30%) and cross-sectional area (CSA) (~ 33%) in DEX-induced muscle atrophy mice model and down-regulated muscle atrophy-associated genes expression (45-65%). Hindlimb grip strength (~ 37%) and forelimb ex vivo muscle contraction property were significantly improved (~ 57%) in the treatment group. Significant increase in type I fibres (~ 77%) was found after ADSC injection. RNA-sequencing results suggested that ERK1/2 signalling pathway might be playing important role underlying the beneficial effect of ADSC treatment, which was confirmed by ERK1/2 inhibitor both in vitro and in vivo. Conclusions: ADSCs restore the pathogenesis of Dex-induced muscle atrophy with an increased number of type I fibres, stronger muscle strength, faster recovery rate and more anti-fatigue ability via ERK1/2 signalling pathway. The inhibition of muscle atrophy-associated genes by ADSCs offered this treatment as an intervention option for muscle-associated diseases. Taken together, our findings suggested that adipose-derived mesenchymal stem cell therapy could be a new treatment option for patient with Dex-induced muscle atrophy.

Study on the mitochondrial mass change in dexamethasone induced mouse thymocyte apoptosis

The mitochondrial and structural protein changes in dexamethasone- induced mouse thymocyte apoptosis

[Inhibitory Effect of Dexamethasone on Myeloid Differentiation Factor 88 and Tumor Necrosis Factor-Alpha Expressions in Mouse Peritoneal Macrophages].

Protecting effects of dexamethasone on thymus of rats with severe acute pancreatitis.

Study on the mechanism of glucocorticoid receptor mitochondrial translocation and glucocorticoid-induced apoptosis in macrophages

High-Dose Dexamethasone Manipulates the Tumor Microenvironment and Internal Metabolic Pathways in Anti-Tumor Progression

Reduced Mitochondrial Response Sensitivity is Involved in the Anti‑apoptotic Effect of Dexmedetomidine Pretreatment in Cardiomyocytes.

[Interaction between necroptosis and apoptosis in MC3T3-E1 cell death induced by dexamethasone].

Inhibitory Effect of Lithium Chloride on Mouse Thymocyte Apoptosis

Conjugation of Dexamethasone to C60 for the Design of an Anti-Inflammatory Nanomedicine with Reduced Cellular Apoptosis.

Dexamethasone-induced production of reactive oxygen species promotes apoptosis via endoplasmic reticulum stress and autophagy in MC3T3-E1 cells

Mass Spectrometry Imaging (MSI) Delineates Thymus-Centric Metabolism In Vivo as an Effect of Systemic Administration of Dexamethasone

A Serum-Pharmacological Study and Effect of Yu-Ping-Feng Powder on Apoptosis of Thymocytes in Mice

[Anti-Oxidative Effects of Dexamethasone on Mice with Experimental Autoimmune Encephalomyelitis].

Effects of Dexamethasone on Acute Myocardial Injury induced by Isoproterenol and T Cells in Spleen

Expression of P38mapk in Human MCF-7 Breast Cancer Cells Treated by Dexamethasone

Mesenchymal stem cells alleviate dexamethasone-induced muscle atrophy in mice and the involvement of ERK1/2 signalling pathway

Comparative analysis of the effects of cyclophosphamide and dexamethasone on intestinal immunity and microbiota in delayed hypersensitivity mice

Dexamethasone Treatment at the Myoblast Stage Enhanced C2C12 Myocyte Differentiation

Characterizing the metabolic profile of dexamethasone treated human trabecular meshwork cells

Study on apoptosis of lens epithelial cells induced by dexamethasone